Outcomes of surgery for young children with multivessel pulmonary vein stenosis Luis G. Quinonez, MD, Kimberlee Gauvreau, PhD, Michele Borisuk, NP, Christina.

Slides:

Advertisements

Similar presentations

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

Advertisements

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Surgery for congenital diseases of the aorta

Valve-sparing aortic root replacement and remodeling with complex aortic valve reconstruction in children and young adults with moderate or severe aortic.

Mitral stenosis with pulmonary hypertension: We should operate early

Local recurrence after surgery for non–small cell lung cancer: A recursive partitioning analysis of multi-institutional data Chris R. Kelsey, MD, Kristin.

Kathy J. Jenkins, MD, MPH, Kimberlee Gauvreau, ScD, Jane W

Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures J. Saravana Ganesh, FRCS, Chris.

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant Victor van Berkel, MD, PhD

The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation Arman Kilic, MD,

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn.

Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation

Prolonged QTc affects short-term and long-term outcomes in patients with normal left ventricular function undergoing cardiac surgery Nattachai Anantasit,

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer Kyong-Ah Yoon,

Pulmonary vein stenosis: Challenges ahead

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Right internal thoracic artery or saphenous vein grafting

Survival after resection of synchronous non–small cell lung cancer

Pulmonary hypertension in valve disease: A beast of the past?

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Form ever follows function

William M. DeCampli, MD, PhD

Bilateral pulmonary arterial banding results in an increased need for subsequent pulmonary artery interventions Ryan R. Davies, MD, Wolfgang A. Radtke,

Application of a neuroscience research model to study neuroprotection in children with congenital heart disease Nobuyuki Ishibashi, MD, Richard A. Jonas,

It is still mostly about the mitral valve

Outcomes in lung transplantation after previous lung volume reduction surgery in a contemporary cohort Leah Backhus, MD, Jonathon Sargent, BS, Aaron.

The lord of the rings Antonio Miceli, MD, PhD

Technical Performance Scores are strongly associated with early mortality, postoperative adverse events, and intensive care unit length of stay—analysis.

Impact of prior hospital mortality versus surgical volume on mortality following surgery for congenital heart disease Matthew E. Oster, MD, Matthew J.

Outcomes after mechanical aortic valve replacement in children and young adults with congenital heart disease Patrick O. Myers, MD, Suyog A. Mokashi,

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Innovation and science: The future of valve design

It's not “just a shunt” but sometimes it should be…

Michele Gallo, MD, Gino Gerosa, MD

A first start for lung transplantation?

Arterial lactate before initiation of venoarterial extracorporeal membrane oxygenation for postcardiotomy shock improves postimplant outcome prediction

Sitaram M. Emani, MD, Breanna L

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Impact of low donor to recipient weight ratios on cardiac transplantation Senthil Nathan Jayarajan, MD, Sharven Taghavi, MD, Eugene Komaroff, PhD, Abeel.

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Biomaterials for heart valve replacement: Conjectures and refutations

Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes Sitaram M. Emani, MD The Journal of Thoracic.

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Apparently, size matters…in congenital heart disease and brain injury

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices Forum Kamdar, MD, Ranjit John,

Surgical outcomes after cardiac surgery in liver transplant recipients

The continuing challenge of congenital heart disease in China

Outcome after repair of atrioventricular septal defect with tetralogy of Fallot Jeffrey H. Shuhaiber, MD, Barbara Robinson, MD, Kimberlee Gauvreau, ScD,

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

“The more things change…”: The challenges ahead

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Preoperative PFTs: The answer is blowing in the wind

Kalpaj Parekh, MD, Bryan F. Meyers, MD, G

Successful implantation of a Berlin heart biventricular assist device in a failing single ventricle Meena Nathan, MD, Christopher Baird, MD, Francis.

How do we follow up our patients

Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks! W. Hampton Gray, MD, P. Michael.

Kristin A. Higgins, MD, Junzo P. Chino, MD, Neal Ready, MD, Mark W

Presentation transcript:

Outcomes of surgery for young children with multivessel pulmonary vein stenosis Luis G. Quinonez, MD, Kimberlee Gauvreau, PhD, Michele Borisuk, NP, Christina Ireland, NP, Audrey M. Marshall, MD, John E. Mayer, MD, Kathy J. Jenkins, MD, Francis E. Fynn-Thompson, MD, Christopher W. Baird, MD The Journal of Thoracic and Cardiovascular Surgery Volume 150, Issue 4, Pages 911-917 (October 2015) DOI: 10.1016/j.jtcvs.2015.06.050 Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Kaplan-Meier survival curve of patients operated for multivessel pulmonary vein stenosis. In the primary group (ie, those without associated congenital heart disease), estimated survival is 57% at both 1 and 2 years postsurgery (95% confidence interval [CI], 26%-78%). In the nonprimary group (ie, those with associated congenital heart disease), estimated survival is 73% (95% CI, 48%-87%) at 1 year and 60% (95% CI, 34%-78%) at 2 years. The Journal of Thoracic and Cardiovascular Surgery 2015 150, 911-917DOI: (10.1016/j.jtcvs.2015.06.050) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Transplant-free survival: Composite end point of death and lung transplantation. In the primary group (ie, those without associated congenital heart disease), estimated transplant-free survival is 38% at both 1 and 2 years postsurgery (95% confidence interval [CI], 12%-64%). In the nonprimary group (ie, those with associated congenital heart disease), estimated survival is 73% (95% CI, 48%-87%) at 1 year and 60% (95% CI, 34%-78%) at 2 years. The Journal of Thoracic and Cardiovascular Surgery 2015 150, 911-917DOI: (10.1016/j.jtcvs.2015.06.050) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Kaplan-Meier survival curve of patients undergoing operation for multivessel pulmonary vein stenosis. The Journal of Thoracic and Cardiovascular Surgery 2015 150, 911-917DOI: (10.1016/j.jtcvs.2015.06.050) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions